SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000903423-19-000003
Filing Date
2019-01-03
Accepted
2019-01-03 17:21:33
Documents
2

Document Format Files

Seq Description Document Type Size
1 urovant13da1.htm SC 13D/A 215583
2 urovant13daex991.htm EX-99.1 5018
  Complete submission text file 0000903423-19-000003.txt   222076
Mailing Address 55 RAILROAD AVENUE GREENWICH CT 06830
Business Address 55 RAILROAD AVENUE GREENWICH CT 06830 212-672-7050
VIKING GLOBAL INVESTORS LP (Filed by) CIK: 0001103804 (see all company filings)

IRS No.: 134055118 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A

Mailing Address 5151 CALIFORNIA AVENUE SUITE 250 IRVINE CA 92617
Business Address 5151 CALIFORNIA AVENUE SUITE 250 IRVINE CA 92617 949-226-6029
Urovant Sciences Ltd. (Subject) CIK: 0001740547 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 0331
Type: SC 13D/A | Act: 34 | File No.: 005-90671 | Film No.: 19507022
SIC: 2834 Pharmaceutical Preparations